ISM1 and neoplasm: Genomewide tumor DNA methylation was measured using the Human Methylation 450K (HM450K) BeadChip array and Suman et al. (49) proved that ISM1 might serve as a biomarker for the prognosis of patients with lobular breast cancer that the methylation clusters were mainly located in the promoter region of the gene.